Harmony Biosciences Holdings, Inc. (HRMY)

NASDAQ: HRMY · Real-Time Price · USD

38.41

-0.34 (-0.88%)

Aug 7, 2026, 4:00 PM EDT - Market closed

HRMY Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	959.9	868.45	714.73	582.02	437.86	305.44
Revenue Growth	24.25%	21.51%	22.80%	32.93%	43.35%	91.21%
Gross Profit	723.99	670.11	557.92	460.79	354.37	249.92
Operating Income	230.65	208.47	190.83	192.03	120.19	87.53
Net Income	181.27	158.69	145.49	128.85	181.47	34.6
Earnings Per Share	3.08	2.71	2.51	2.13	2.97	0.58
EPS Growth	-0.65%	7.97%	17.84%	-28.28%	412.07%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	667.79	775.34	467.19	353.46	323.12	234.31
Total Debt	153.96	163.66	179.27	193.57	191.65	191.98
Net Cash (Debt)	513.83	611.68	287.92	159.89	131.47	42.33
Net Cash Growth	30.69%	112.45%	80.07%	21.62%	210.62%	23.11%
Net Cash Per Share	8.75	10.45	4.98	2.65	2.15	0.71

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	355.08	348.2	219.82	219.39	144.47	98.56
Capital Expenditures	-0.18	-0.31	-1.15	-0.31	-0.17	-0.3
Free Cash Flow	354.9	347.89	218.67	219.08	144.29	98.26
Free Cash Flow Growth	37.17%	59.09%	-0.19%	51.82%	46.85%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	75.42%	77.16%	78.06%	79.17%	80.93%	81.82%
Operating Margin	24.03%	24.00%	26.70%	32.99%	27.45%	28.66%
Pretax Margin	25.13%	24.76%	26.84%	29.79%	23.91%	12.25%
Profit Margin	18.88%	18.27%	20.36%	22.14%	41.44%	11.33%
FCF Margin	36.97%	40.06%	30.59%	37.64%	32.95%	32.17%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.43	13.81	13.71	15.16	18.55	73.52
Forward PE	9.75	10.05	11.82	11.14	23.01	25.27
P/FCF Ratio	6.30	6.21	8.99	8.37	22.76	25.53
PS Ratio	2.33	2.49	2.75	3.15	7.50	8.21